Evidence map›Paper›PMID 16193333›Full record

ArticlePsychopharmacology2005

Alpha(1)-adrenergic and alpha(2)-adrenergic balance in the dorsal pons and gross behavioral activity of mice in a novel environment.

Eric A Stone, Yan Lin, Mohammad R Ahsan, David Quartermain

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eric A StoneDepartment of Psychiatry, New York University School of Medicine, 550 First Ave., New York, NY, 10016, USA.
Yan Lin
Mohammad R Ahsan
David Quartermain
New York University · US

Funding

REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR01MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 2000 to 2010
$3.1M
POSTDOCTORAL TRAINING IN RESEARCH ON ABUSED DRUGST32DA007254 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARR, KENNETH D · 1991 to 2013
$2.5M
REGULATION OF BRAIN NORADRENERGIC NEUROTRANSMISSIONR37MH045265 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STONE, ERIC A · 1989 to 1996
–
NIDA NIH HHS T32 DA07254NIMH NIH HHS MH45265
6 · The paper itself

Abstract

rationaleCentral alpha(1)- and alpha(2)-adrenoceptors in a number of different brain regions are known to have opposing actions on gross behavioral activity, with the former stimulating and the latter inhibiting activity. Therefore, blockade of alpha(1)-receptors may induce inactivity by leading to unopposed alpha(2) activity.

objectiveThe aim of this study was to test if central blockade of alpha(2)-receptor function restores behavioral activity in alpha(1)-receptor-blocked mice.

methodsDose-response studies were undertaken on the effects of alpha(1)- and alpha(2)-agonists and antagonists microinjected into the dorsal pons on gross behavioral activity in a novel cage test.

resultsThe behavioral inactivity resulting from blockade of alpha(1)-receptors in the pons with the antagonist, terazosin, was reversed by either a low dose of an alpha(2)-antagonist, atipamezole, or a low dose of an alpha(2)-agonist, dexmedetomidine, but was exacerbated by a high dose of the alpha(2)-agonist.

conclusionThe results support the hypothesis that blockade of alpha(1)-receptors in the dorsal pons of mice produces inactivity by causing unopposed activity of alpha(2)-receptors. This condition may be relevant to inactive states seen after stress or during depressive illness.

Indexed as

Adrenergic alpha-AgonistsAdrenergic alpha-AntagonistsAdrenergic beta-AgonistsAnimalsBehavior, AnimalDexmedetomidineDose-Response Relationship, DrugEnvironmentImidazolesMaleMiceMotor ActivityPonsPrazosinReceptors, Adrenergic, alpha-1Receptors, Adrenergic, alpha-2Adrenergic alpha-AgonistsAdrenergic alpha-AntagonistsAdrenergic beta-AgonistsatipamezoleDexmedetomidineImidazolesPrazosinReceptors, Adrenergic, alpha-1Receptors, Adrenergic, alpha-2Terazosin

Identifiers

PMID16193333
OpenAlexW2059278176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.